Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
SubbaRao V. Madhunapantula, Paul J. Mosca & Gavin P. Robertson. (2011) The Akt signaling pathway. Cancer Biology & Therapy 12:12, pages 1032-1049.
Read now
Read now
Margrith E Mattmann, Sydney L Stoops & Craig W Lindsley. (2011) Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape. Expert Opinion on Therapeutic Patents 21:9, pages 1309-1338.
Read now
Read now
Zhijie Li & Carol J Thiele. (2007) Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway. Expert Opinion on Therapeutic Targets 11:12, pages 1611-1621.
Read now
Read now
Qun Li. (2007) Recent progress in the discovery of Akt inhibitors as anticancer agents. Expert Opinion on Therapeutic Patents 17:9, pages 1077-1130.
Read now
Read now
Articles from other publishers (34)
Yanqing Li, Ziyu Luo, Xinxing Wang, Songtao Zhang, Hu Hei & Jianwu Qin. (2022) Design of new drugs for medullary thyroid carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Shazmeen, Iahtisham‐Ul Haq, Muhammad Shahid Riaz Rajoka, Muhmmad Asim Shabbir, Muhammad Umair, Inam‐u llah, Muhammad Faisal Manzoor, Arash Nemat, Muhammad Abid, Moazzam Rafiq Khan & Rana Muhammad Aadil. (2021) Role of stilbenes against insulin resistance: A review. Food Science & Nutrition 9:11, pages 6389-6405.
Crossref
Crossref
Elena M. Sánchez-Fernández, Ma Isabel García-Moreno, Ana I. Arroba, Manuel Aguilar-Diosdado, José M. Padrón, Raquel García-Hernández, Francisco Gamarro, Santos Fustero, José-Emilio Sánchez-Aparicio, Laura Masgrau, José Manuel García Fernández & Carmen Ortiz Mellet. (2019) Synthesis of polyfluoroalkyl sp2-iminosugar glycolipids and evaluation of their immunomodulatory properties towards anti-tumor, anti-leishmanial and anti-inflammatory therapies. European Journal of Medicinal Chemistry 182, pages 111604.
Crossref
Crossref
Cheryl S. Gradziel, Peter A. Jordan, Delilah Jewel, Fay J. Dufort, Scott J. Miller, Thomas C. Chiles & Mary F. Roberts. (2016) d -3-Deoxy-dioctanoylphosphatidylinositol induces cytotoxicity in human MCF-7 breast cancer cells via a mechanism that involves downregulation of the D-type cyclin-retinoblastoma pathway. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1861:11, pages 1808-1815.
Crossref
Crossref
Wenjuan Liu, Yonghao Qi, Lingyu Liu, Yu Tang, Jing Wei & Lijun Zhou. (2016) Suppression of tumor cell proliferation by quinine via the inhibition of the tumor necrosis factor receptor-associated factor 6-AKT interaction. Molecular Medicine Reports 14:3, pages 2171-2179.
Crossref
Crossref
Kristina Mäemets-Allas, Janeli Viil & Viljar Jaks. (2015)
A Novel Inhibitor of AKT1–PDPK1 Interaction Efficiently Suppresses the Activity of AKT Pathway and Restricts Tumor Growth
In Vivo
. Molecular Cancer Therapeutics 14:11, pages 2486-2496.
Crossref
Crossref
Mahmoud A. Al-Sha’er, Iman Mansi, Inas Almazari & Nancy Hakooz. (2015) Evaluation of novel Akt1 inhibitors as anticancer agents using virtual co-crystallized pharmacophore generation. Journal of Molecular Graphics and Modelling 62, pages 213-225.
Crossref
Crossref
Jean-Marc Zingg. (2015) Vitamin E: A Role in Signal Transduction. Annual Review of Nutrition 35:1, pages 135-173.
Crossref
Crossref
Ananya Datta Mitra, Siba P. Raychaudhuri, Christine J. Abria, Anupam Mitra, Rebecca Wright, Rahul Ray & Smriti Kundu-Raychaudhuri. (2013) 1α,25-Dihydroxyvitamin-D3-3-Bromoacetate Regulates AKT/mTOR Signaling Cascades: A Therapeutic Agent for Psoriasis. Journal of Investigative Dermatology 133:6, pages 1556-1564.
Crossref
Crossref
Vanessa Brandes, Ilona Schelle, Sophie Brinkmann, Florian Schulz, Janett Schwarz, Ralf Gerhard & Harald Genth. (2012) Protection from Clostridium difficile toxin B-catalysed Rac1/Cdc42 glucosylation by tauroursodeoxycholic acid-induced Rac1/Cdc42 phosphorylation. Biological Chemistry 393:1-2.
Crossref
Crossref
James R. Lambert, Vikram J. Eddy, Christian D. Young, Kelly S. Persons, Sibaji Sarkar, Julie A. Kelly, Elizabeth Genova, M. Scott Lucia, Douglas V. Faller & Rahul Ray. (2010) A Vitamin D Receptor-Alkylating Derivative of 1α,25-Dihydroxyvitamin D3 Inhibits Growth of Human Kidney Cancer Cells and Suppresses Tumor Growth. Cancer Prevention Research 3:12, pages 1596-1607.
Crossref
Crossref
Qin Wang, Yang Wei, Madhusoodanan Mottamal, Mary F. Roberts & Goran Krilov. (2010) Understanding the stereospecific interactions of 3-deoxyphosphatidylinositol derivatives with the PTEN phosphatase domain. Journal of Molecular Graphics and Modelling 29:1, pages 102-114.
Crossref
Crossref
Jean-Marc Zingg, Mohsen Meydani & Angelo Azzi. (2010) α-Tocopheryl phosphate - An active lipid mediator?. Molecular Nutrition & Food Research 54:5, pages 679-692.
Crossref
Crossref
Michael D. Best, Honglu Zhang & Glenn D. Prestwich. (2010) Inositol polyphosphates, diphosphoinositol polyphosphates and phosphatidylinositol polyphosphate lipids: Structure, synthesis, and development of probes for studying biological activity. Natural Product Reports 27:10, pages 1403.
Crossref
Crossref
Pixu Liu, Hailing Cheng, Thomas M. Roberts & Jean J. Zhao. (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nature Reviews Drug Discovery 8:8, pages 627-644.
Crossref
Crossref
Yanling K. Wang, Wei Chen, Derek Blair, Mingming Pu, Yingju Xu, Scott J. Miller, Alfred G. Redfield, Thomas C. Chiles & Mary F. Roberts. (2008) Insights into the Structural Specificity of the Cytotoxicity of 3-Deoxyphosphatidylinositols. Journal of the American Chemical Society 130:24, pages 7746-7755.
Crossref
Crossref
Akhlaq A. Farooqui, Tahira Farooqui & Lloyd A. Horrocks. 2008. Metabolism and Functions of Bioactive Ether Lipids in the Brain. Metabolism and Functions of Bioactive Ether Lipids in the Brain
1
16
.
Jean-Marc Zingg. (2007) Modulation of signal transduction by vitamin E. Molecular Aspects of Medicine 28:5-6, pages 481-506.
Crossref
Crossref
Masayuki Noguchi, Virginie Ropars, Christian Roumestand & Futoshi Suizu. (2007) Proto‐oncogene TCL1: more than just a coactivator for Akt. The FASEB Journal 21:10, pages 2273-2284.
Crossref
Crossref
Maw-Ling Wang & Ze-Fa Lee. (2007) Reaction of 4,4′-bis(chloromethyl)-1,1′-biphenyl and phenol in two-phase medium via phase-transfer catalysis. Journal of Molecular Catalysis A: Chemical 264:1-2, pages 119-127.
Crossref
Crossref
Thomas G. Davies, Marcel L. Verdonk, Brent Graham, Susanne Saalau-Bethell, Christopher C.F. Hamlett, Tatiana McHardy, Ian Collins, Michelle D. Garrett, Paul Workman, Steven J. Woodhead, Harren Jhoti & David Barford. (2007) A Structural Comparison of Inhibitor Binding to PKB, PKA and PKA-PKB Chimera. Journal of Molecular Biology 367:3, pages 882-894.
Crossref
Crossref
Gui-Dong Zhu, Jianchun Gong, Viraj B. Gandhi, Keith Woods, Yan Luo, Xuesong Liu, Ran Guan, Vered Klinghofer, Eric F. Johnson, Vincent S. Stoll, Mulugeta Mamo, Qun Li, Saul H. Rosenberg & Vincent L. Giranda. (2007) Design and synthesis of pyridine–pyrazolopyridine-based inhibitors of protein kinase B/Akt. Bioorganic & Medicinal Chemistry 15:6, pages 2441-2452.
Crossref
Crossref
A.A. Mortlock & A.J. Barker. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
183
220
.
Akhlaq A. Farooqui & Lloyd A. Horrocks. 2007. Glycerophospholipids in the Brain. Glycerophospholipids in the Brain
35
66
.
Gui-Dong Zhu, Viraj B. Gandhi, Jianchun Gong, Yan Luo, Xuesong Liu, Yan Shi, Ran Guan, Shayna R. Magnone, Vered Klinghofer, Eric F. Johnson, Jennifer Bouska, Alexander Shoemaker, Anatol Oleksijew, Ken Jarvis, Chang Park, Ron De Jong, Tilman Oltersdorf, Qun Li, Saul H. Rosenberg & Vincent L. Giranda. (2006) Discovery and SAR of oxindole–pyridine-based protein kinase B/Akt inhibitors for treating cancers. Bioorganic & Medicinal Chemistry Letters 16:13, pages 3424-3429.
Crossref
Crossref
A M Martelli, M Nyåkern, G Tabellini, R Bortul, P L Tazzari, C Evangelisti & L Cocco. (2006) Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 20:6, pages 911-928.
Crossref
Crossref
Gui-Dong Zhu, Jianchun Gong, Akiyo Claiborne, Keith W. Woods, Viraj B. Gandhi, Sheela Thomas, Yan Luo, Xuesong Liu, Yan Shi, Ran Guan, Shayna R. Magnone, Vered Klinghofer, Eric F. Johnson, Jennifer Bouska, Alexander Shoemaker, Anatol Oleksijew, Vincent S. Stoll, Ron De Jong, Tilman Oltersdorf, Qun Li, Saul H. Rosenberg & Vincent L. Giranda. (2006) Isoquinoline–pyridine-based protein kinase B/Akt antagonists: SAR and in vivo antitumor activity. Bioorganic & Medicinal Chemistry Letters 16:12, pages 3150-3155.
Crossref
Crossref
Qun Li, Keith W. Woods, Sheela Thomas, Gui-Dong Zhu, Garrick Packard, John Fisher, Tongmei Li, Jianchun Gong, Jurgen Dinges, Xiaohong Song, Jason Abrams, Yan Luo, Eric F. Johnson, Yan Shi, Xuesong Liu, Vered Klinghofer, Ron Des Jong, Tilman Oltersdorf, Vincent S. Stoll, Clarissa G. Jakob, Saul H. Rosenberg & Vincent L. Giranda. (2006) Synthesis and structure–activity relationship of 3,4′-bispyridinylethylenes: Discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters 16:7, pages 2000-2007.
Crossref
Crossref
Qun Li, Tongmei Li, Gui-Dong Zhu, Jianchun Gong, Akiyo Claibone, Chris Dalton, Yan Luo, Eric F. Johnson, Yan Shi, Xuesong Liu, Vered Klinghofer, Joy L. Bauch, Kennan C. Marsh, Jennifer J. Bouska, Shannon Arries, Ron De Jong, Tilman Oltersdorf, Vincent S. Stoll, Clarissa G. Jakob, Saul H. Rosenberg & Vincent L. Giranda. (2006) Discovery of trans-3,4′-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters 16:6, pages 1679-1685.
Crossref
Crossref
Pradip K Majumder & William R Sellers. (2005) Akt-regulated pathways in prostate cancer. Oncogene 24:50, pages 7465-7474.
Crossref
Crossref
Chandra C Kumar & Vincent Madison. (2005) AKT crystal structure and AKT-specific inhibitors. Oncogene 24:50, pages 7493-7501.
Crossref
Crossref
Soo-Jin Jeong, Cynthia A Pise-Masison, Michael F Radonovich, Hyeon Ung Park & John N Brady. (2005) Activated AKT regulates NF-κB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 24:44, pages 6719-6728.
Crossref
Crossref
Roberta Bortul, Pier Luigi Tazzari, Anna Maria Billi, Giovanna Tabellini, Irina Mantovani, Alessandra Cappellini, Tiziana Grafone, Giovanni Martinelli, Roberto Conte & Alberto M. Martelli. (2005) Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. British Journal of Haematology 129:5, pages 677-686.
Crossref
Crossref
Zhijie Li, Jerry Jaboin, Phillip A. Dennis & Carol J. Thiele. (2005) Genetic and Pharmacologic Identification of Akt as a Mediator of Brain-Derived Neurotrophic Factor/TrkB Rescue of Neuroblastoma Cells from Chemotherapy-Induced Cell Death. Cancer Research 65:6, pages 2070-2075.
Crossref
Crossref